(412) 364-8200 | Monday - Friday, 8am to 5pm ET
One of the most closely watched elements of CMS’s 2026 proposal concerns whether Medicare should continue requiring evidence collection for TAVR. Ending coverage with evidence development (CED) for symptomatic patients…
To understand why CMS’s 2026 proposal feels so consequential, it helps to see what it is unwinding. For more than a decade, Medicare’s coverage of transcatheter aortic valve replacement (TAVR)…
When Medicare first covered transcatheter aortic valve replacement (TAVR) in 2012, it did so cautiously — paying only when patients were enrolled in a national registry and treated at centers…
Transcatheter Aortic Valve Replacement (TAVR) involve procedures to replace a damaged aortic valve with a prosthetic one through minimally invasive techniques. Building a TAVR program requires careful planning that includes…
In the ever-evolving field of healthcare, advancements in technology have paved the way for innovative treatments that promise better outcomes and improved quality of life for patients. Transcatheter Aortic Valve…
A recent article in Circulation, published online ahead of print, addressed a retrospective cohort study using data from the STS/ACC TVT Registry which concluded that significant differences in the quality…
company 
